Biocube Stock EBITDA
| BICB Stock | USD 0.0002 0.00 0.00% |
BioCube fundamentals help investors to digest information that contributes to BioCube's financial success or failures. It also enables traders to predict the movement of BioCube Pink Sheet. The fundamental analysis module provides a way to measure BioCube's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to BioCube pink sheet.
BioCube |
BioCube Company EBITDA Analysis
BioCube's EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Current BioCube EBITDA | 77.36 K |
Most of BioCube's fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, BioCube is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
| Competition |
According to the company disclosure, BioCube reported earnings before interest,tax, depreciation and amortization of 77.36 K. This is 100.0% lower than that of the Financial Services sector and significantly higher than that of the Shell Companies industry. The ebitda for all United States stocks is 100.0% higher than that of the company.
Did you try this?
Run Bonds Directory Now
Bonds DirectoryFind actively traded corporate debentures issued by US companies |
| All Next | Launch Module |
BioCube Fundamentals
| Current Valuation | 3.84 M | |||
| Shares Outstanding | 44.84 M | |||
| Shares Owned By Institutions | 0.07 % | |||
| Price To Earning | (0.65) X | |||
| Price To Sales | 0 X | |||
| EBITDA | 77.36 K | |||
| Net Income | (534.8 K) | |||
| Cash And Equivalents | 39 | |||
| Total Debt | 1.03 M | |||
| Book Value Per Share | (0.04) X | |||
| Cash Flow From Operations | 210 | |||
| Earnings Per Share | (0.02) X | |||
| Beta | 0.87 | |||
| Market Capitalization | 3.14 M | |||
| Total Asset | 100 K | |||
| Retained Earnings | (2.35 M) | |||
| Working Capital | (1.56 M) | |||
| Current Liabilities | 1.56 M | |||
| Z Score | -48.4 | |||
| Net Asset | 100 K |
About BioCube Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze BioCube's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of BioCube using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of BioCube based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| BTC | Bitcoin | |
| TRX | TRON | |
| BNB | Binance Coin |
Other Information on Investing in BioCube Pink Sheet
BioCube financial ratios help investors to determine whether BioCube Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in BioCube with respect to the benefits of owning BioCube security.